I agree there's no similarity, but we need to keep in mind that many holders aren't sensationally well informed, particularly in this sector, so when another company like IIL suffering a company ending setback, then I think it reasonable to expect slight contamination in the fallout, however irrational that may be.
You're bang on though, I think once we hit July, there may be a few holders paying a premium to get back in.
Ann: Cynata Therapeutics GvHD Clinical Trial & Corporate Progress, page-39
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $8.739K | 34.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19841 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 15.44pm 18/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |